Seer, Inc. is a life sciences company. It is developing products that open a new gateway to the proteome. Its Proteograph product suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. The Proteograph has detected over 36,000 proteins across multiple species, and its performance and capabilities have been demonstrated in over 33 peer-reviewed publications, preprints and reviews. The Proteograph Product Suite is detector-agnostic and is adaptable to other protein detection instruments. The MS component of the Proteograph workflow is either provided by the researcher’s laboratory, can be outsourced to a third-party provider, or be run through the Seer Technology Access Center (STAC), which is its in-house service program. It has launched Proteograph XT, which enhances the sample throughput of the Proteograph Product Suite and MS instrument.
公司代碼SEER
公司名稱Seer Inc
上市日期Dec 04, 2020
CEOFarokhzad (Omid C)
員工數量134
證券類型Ordinary Share
年結日Dec 04
公司地址3800 Bridge Parkway, Suite 102
城市REDWOOD CITY
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94065
電話16504530000
網址https://seer.bio/
公司代碼SEER
上市日期Dec 04, 2020
CEOFarokhzad (Omid C)